» Articles » PMID: 29531323

Pre-B Acute Lymphoblastic Leukaemia Recurrent Fusion, EP300-ZNF384, is Associated with a Distinct Gene Expression

Overview
Journal Br J Cancer
Specialty Oncology
Date 2018 Mar 14
PMID 29531323
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Zinc-finger protein 384 (ZNF384) fusions are an emerging subtype of precursor B-cell acute lymphoblastic leukaemia (pre-B-ALL) and here we further characterised their prevalence, survival outcomes and transcriptome.

Methods: Bone marrow mononuclear cells from 274 BCR-ABL1-negative pre-B-ALL patients were immunophenotyped and transcriptome molecularly characterised. Transcriptomic data was analysed by principal component analysis and gene-set enrichment analysis to identify gene and pathway expression changes.

Results: We exclusively detect E1A-associated protein p300 (EP300)-ZNF384 in 5.7% of BCR-ABL1-negative adolescent/young adult (AYA)/adult pre-B-ALL patients. EP300-ZNF384 patients do not appear to be a high-risk subgroup. Transcriptomic analysis revealed that EP300-ZNF384 samples have a distinct gene expression profile that results in the up-regulation of Janus kinase/signal transducers and activators of transcription (JAK/STAT) and cell adhesion pathways and down-regulation of cell cycle and DNA repair pathways.

Conclusions: Importantly, this report contributes to a better overview of the incidence of EP300-ZNF384 patients and show that they have a distinct gene signature with concurrent up-regulation of JAK-STAT pathway, reduced expression of B-cell regulators and reduced DNA repair capacity.

Citing Articles

RanBALL: An Ensemble Random Projection Model for Identifying Subtypes of B-Cell Acute Lymphoblastic Leukemia.

Li L, Xiao H, Wu X, Tang Z, Khoury J, Wang J bioRxiv. 2024; .

PMID: 39386448 PMC: 11463541. DOI: 10.1101/2024.09.24.614777.


The Molecular and Biological Function of MEF2D in Leukemia.

Zhang P, Lu R Adv Exp Med Biol. 2024; 1459:379-403.

PMID: 39017853 DOI: 10.1007/978-3-031-62731-6_17.


EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.

Hou Z, Ren Y, Zhang X, Huang D, Yan F, Sun W Cell Commun Signal. 2024; 22(1):211.

PMID: 38566191 PMC: 10986138. DOI: 10.1186/s12964-024-01596-9.


The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age.

Beder T, Hansen B, Hartmann A, Zimmermann J, Amelunxen E, Wolgast N Hemasphere. 2023; 7(9):e939.

PMID: 37645423 PMC: 10461941. DOI: 10.1097/HS9.0000000000000939.


ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.

Zhu L, Bai W, Cheng Q, Fang J Cancer Control. 2023; 30:10732748231182787.

PMID: 37306722 PMC: 10272635. DOI: 10.1177/10732748231182787.


References
1.
Iyer N, Chin S, Ozdag H, Daigo Y, Hu D, Cariati M . p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad Sci U S A. 2004; 101(19):7386-91. PMC: 409928. DOI: 10.1073/pnas.0401002101. View

2.
Lilljebjorn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S . Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016; 7:11790. PMC: 4897744. DOI: 10.1038/ncomms11790. View

3.
Evans P, Zhang W, Chen X, Yang J, Bhakat K, Liu C . Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem. 2007; 282(47):33994-4002. DOI: 10.1074/jbc.M701847200. View

4.
La Starza R, Aventin A, Crescenzi B, Gorello P, Specchia G, Cuneo A . CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. Leukemia. 2005; 19(9):1696-9. DOI: 10.1038/sj.leu.2403842. View

5.
Shago M, Abla O, Hitzler J, Weitzman S, Abdelhaleem M . Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion. Pediatr Blood Cancer. 2016; 63(11):1915-21. DOI: 10.1002/pbc.26116. View